Also remember ARX maintained their guidance of $34-37M for FY22 on 28 Jan 2022. Which was approx 3 days after peak of hospitalisations in this COVID wave. So if ARX was still maintaining guidance in that environent - id imagine PNV would be similar if not better.
Ann: 1H22 Results Webcast details, page-33
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.25 |
Change
0.050(2.27%) |
Mkt cap ! $1.553B | |||
| Open | High | Low | Value | Volume |
| $2.24 | $2.25 | $2.17 | $3.964M | 1.773M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 22141 | $2.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.25 | 17044 | 4 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.24 |
Change
0.050 ( 2.25 %) |
||||
| Open | High | Low | Volume | ||
| $2.24 | $2.25 | $2.17 | 278730 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| PNV (ASX) Chart |